Carregant...
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes
BACKGROUND: Dysferlinopathies are a group of muscle disorders causing muscle weakness and absence or low levels of dysferlin, a type-II transmembrane protein and the causative gene of these dystrophies. Dysferlin is implicated in vesicle fusion, trafficking, and membrane repair. Muscle biopsy of pat...
Guardat en:
| Publicat a: | BMC Musculoskelet Disord |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7697384/ https://ncbi.nlm.nih.gov/pubmed/33246442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-020-03756-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|